VijayChudasamaDr Vijay Chudasama graduated from University College London (UCL), 2008, where he worked on a novel, versatile approach for the synthesis of 2,4-substituted oxazoles under the tutelage of Dr. Jon Wilden. He received a number of awards/scholarships, including Science, Engineering and Technology (SET) Chemistry Student of the Year (2008) , Bader Prize (2008), Faculty of Mathematical and Physical Sciences Medal and Prize (2008), Tufnell Scholarship (2008), Dean’s list (2008), Franz Sondheimer Prize (2007), Charles Vernon Prize (2007), Jackson-Lewis Scholarship (2006), Christopher-Ingold Scholarship (2005, 2006, 2007) and AstraZeneca Chemistry Bursary (2004, 2005, 2006, 2007).

Following his undergraduate studies, Dr Chudasama obtained his PhD (2011) at UCL working with both Prof. Stephen Caddick and Dr Richard Fitzmaurice on the use of aerobic aldehyde C-H activation for the construction of C-C and C-N bonds. He won a collection of awards/prizes: Ramsay Medal (2011), 1st Prize at Final Year Organic Chemistry and Chemical Biology PhD Presentation Competition (2011),  Lilly Postgraduate Prize Day (2010), 1st Prize at UCL Chemistry Postgraduate Poster Competition (2010)  and UCL Graduate School Research Scholarship (2008, 2009, 2010).

After his graduate work, Dr Chudasama took a year out to work in patent law, before returning to UCL to do a postdoctoral stay in the laboratories of Prof. Stephen Caddick and Dr Mark Smith where he turned his attention to developing novel reagents for cysteine and disulfide functionalisation. In 2013, he was highlighted by Scientific American to be one of 30 scientists, under 30 years old, across the world with promising prospects in Chemistry and selected to attend the 63rd Lindau Nobel Laurette Meeting.

In 2014, Dr Chudasama was awarded a prestigious Ramsay Fellowship in the field of Chemical Biology and was made Technical Director of biologicals company (ThioLogics), which is based on technology he is an inventor of (www.thiologics.com).

In early 2015, Dr Chudasama was appointed to a lectureship at UCL following his being highlighted as a future leader in Science by Forbes magazine and the Royal Society of Chemistry. In late 2015, Dr Chudasama was awarded a UCL Excellence Fellowship to concentrate on work in the context of Chemical Biology.

In 2016, Vijay was cited as being one of CNN News’ 2020 visionaries for his work in the field of antibody-drug conjugates.

The group has research interests in the development and application of novel methodologies in Chemical Biology and Organic Synthesis, resulting in over 35 publications. Particular research highlights include publications in Nature Chemistry, Nature Communications, Chemical Science and Proceedings of the National Academy of Sciences of the U.S.A. In addition, Dr Vijay Chudasama has been highlighted as a future leader in the field of Organic Chemistry by Chemical Communications in a recent special issue (Emerging Investigators 2015).

He is also one of the founders, and the Technical Director, of UCL spin-out ThioLogics™ (http://www.thiologics.com).

For a full research summary, click here.

Dr Chudasama has teaching interests in Organic Chemistry and Chemical Biology.

He leads on tutorials for 1st and 2nd year students, workshops for 1st year students, lectures on a core 2nd year organic chemistry module as well as being course organiser for the 2rd year lab course (CHEM2201), demonstrates on laboratory courses to 1st, 2nd and 3rd year students, and supervises 3rd year literature project students.

Dr Chudasama also runs a laboratory module for New York University London.